Last updated: November 29, 2023
Sponsor: Tanta University
Overall Status: Completed
Phase
3
Condition
Breast Cancer
Cancer
Treatment
regional anesthesia
Clinical Study ID
NCT04239716
mastectomy regional anesthesia
Ages 40-85 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Female patients aged 40-85 years old
- American Society of Anesthesiologists' physical status III and IV
- Planned for modified radical mastectomy with axillary lymph node dissection
Exclusion
Exclusion Criteria:
- Patient refusal
- Neurological or psychiatric disorders
- Local infection at injection site
- Spine or chest wall deformity
- Allergy or any contraindication to any of the study drugs
- Opioid or alcoholic addiction
- Chronic pain of any cause
- Uncooperative patients.
Study Design
Total Participants: 13
Treatment Group(s): 1
Primary Treatment: regional anesthesia
Phase: 3
Study Start date:
January 01, 2022
Estimated Completion Date:
October 31, 2022
Study Description
Connect with a study center
Tanta University, Faculty of Medicine
Tanta, 31527
EgyptSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.